Barbara Murray, MD, 2014 president of the Infectious Diseases Society of America (IDSA), is passed the gavel by 2013 IDSA president David Relman, MD.
Barbara E. Murray, MD, professor and director of the Division of Infectious Diseases at the University of Texas Health Science Center at Houston (UTHealth) Medical School, has become the 2014 president of the Infectious Diseases Society of America (IDSA).
Murray began her term as president on Oct. 4, 2013Â at the annual meeting of the IDSA, the Society for Healthcare Epidemiology of America, the HIV Medicine Association and the Pediatric Infectious Diseases Society in San Francisco. The meeting is called IDWeek.
The IDSA has approximately 10,000 members and its purpose is to improve the health of individuals, communities and society by promoting excellence in patient care, education, research, public health and prevention of infectious diseases. It was founded in 1963.
Murrays research is focused on understanding what makes antibiotic-resistant bacteria or superbugs tick and developing new treatments for them. Superbugs threaten to reverse advances made by infectious disease researchers in the last century
Herbert DuPont, MD, holder of the Mary W. Kelsey Distinguished Chair in the Medical Sciences and director of the Center for Infectious Diseases at The University of Texas School of Public Health, a part of UTHealth, described Murray as a national leader on antibiotic resistance and microbiology, and the importance of enterococci as human pathogens.
DuPont, a past IDSA president, added that Murray as IDSA president has the opportunity to help lead the country in important areas designed to control emerging infectious diseases and reduce the enormous burden of antibiotic resistance.
As a child, Murray experienced the effect of infectious disease firsthand. At the age of 4, she was hospitalized for polio. Later as a medical student, she traveled to Costa Rica, Guatemala and Colombia, where she saw that clinicians spent a considerable amount of their time treating transmissible diseases.
Murray graduated with a degree in mathematics cum laude from Rice University in 1969 and was first in her graduating class from UT Southwestern Medical Center in Dallas in 1973. She spent six years training in internal medicine and infectious diseases at Harvard Medical School and Massachusetts General Hospital. She later spent six months at the Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand.
Murray joined the UTHealth Medical School faculty in 1980 and is now the director of the Center for the Study of Emerging and Re-emerging Pathogens and holder of the J. Ralph Meadows Professorship in Internal Medicine. She has been the director of the Infectious Diseases Division since 1995.
Murray, whose research receives support from the National Institutes of Health, has approximately 300 peer-reviewed publications. She writes for Harrison's Principles of Internal Medicine, the online text UpToDate, and Mandell, Douglas and Bennett's Textbook of Infectious Diseases. She also has written reviews for The New England Journal of Medicine and Nature Reviews in Microbiology.
Source: University of Texas Health Science Center at Houston
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.